1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Erythropoietin Market in Japan 2015-2019

Erythropoietin Market in Japan 2015-2019

  • September 2015
  • -
  • Infiniti Research Limited
  • -
  • 65 pages

Summary

Table of Contents

Search Inside

About erythropoietin
Erythropoietin (EPO), also referred to as hematopoietin or hemopoietin, is a glycoprotein that is responsible for the production of erythrocytes in the body. In the fetal stage, this protein is produced in the liver. However, in adulthood it is produced in the kidneys. During anemic conditions, the body produces an excess of erythropoietin to maintain a normal level of red blood cells. When the endogenous production of erythropoietin is disrupted because of illness or medications, normal red blood cell levels are maintained by an injecting erythropoiesis-stimulating agents (ESAs). These agents are similar to natural erythropoietin in structure and function. They can be produced by recombinant DNA technology and are used in the treatment of anemia resulting from renal disease, cancer, HIV, injuries, or neurological conditions.

Technavio's analysts forecast the erythropoietin market in Japan to decline at a CAGR of (1.16) % over the period 2014-2019.

Covered in this report
In this report, Technavio covers the present scenario and growth prospects of the erythropoietin market in Japan for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of erythropoietin drugs and biosimilars used in the treatment of anemia due to renal disease, chemotherapy, antiretroviral therapy, wounds, or neurological conditions.

Technavio's report, Erythropoietin Market in Japan 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the erythropoietin market in Japan and its growth prospects in the coming years. The report includes a discussion on the key vendors operating in this market.

Key Vendors
- Chugai Pharmaceutical
- JCR Pharmaceuticals
- Kissei Pharmaceutical
- Kyowa Hakko Kirin

Other prominent vendors
- Eisai
- Otsuka
- Taiho Pharmaceutical
- Takeda

Market driver
- Increased incidence of anemia due to illness
- For a full, detailed list, view our report

Market challenge
- High cost of therapy
- For a full, detailed list, view our report

Market trend
- Strategic alliances
- For a full, detailed list, view our report


Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Erythropoietin Drug - Global Market Outlook (2016-2022)

Erythropoietin Drug - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • February 2017
  • by Stratistics MRC

According to Stratistics MRC, the Global Erythropoietin Drug Market is accounted for $8.04 billion in 2016 and is expected to reach $14.4 billion by 2022 growing at a CAGR of 10.2% from 2016 to 2022. ...

Global Erythropoietin Drugs Market 2017-2021

Global Erythropoietin Drugs Market 2017-2021

  • $ 3500
  • Industry report
  • March 2017
  • by Infiniti Research Limited

About Erythropoietin Drugs The global erythropoietin drugs market is expected to witness a slow growth rate during the forecast period. In 2016, EMEA dominated the market, followed by the Americas and ...

Downstream Processing Market by Technique (Separation, Concentration, Purification), Product (Chromatography Column & Resin, Filter, Single use), Application (Mab Production) and End User (Contract Manufacturing Organization) - Global Forecast to 2021

Downstream Processing Market by Technique (Separation, Concentration, Purification), Product (Chromatography Column & Resin, Filter, Single use), Application (Mab Production) and End User (Contract Manufacturing Organization) - Global Forecast to 2021

  • $ 5650
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global downstream processing market is projected to reach USD 22.03 billion by 2021 from USD 10.32 billion in 2016, at a CAGR of 16.4% from 2016 to 2021. Increasing demand for biopharmaceuticals and ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.